CompletedPhase 2NCT00006227
Paclitaxel in Treating Patients With Ovarian Stromal Cancer
Studying Gynandroblastoma
Last synced from ClinicalTrials.gov
ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing dataKey facts
- Sponsor
- Gynecologic Oncology Group
- Principal Investigator
- Linda Van LeNRG Oncology
- Intervention
- Paclitaxel(drug)
- Enrollment
- 31 enrolled
- Eligibility
- FEMALE
- Timeline
- 2000 – 2016
Study locations (30)
- University of Alabama at Birmingham Cancer Center, Birmingham, Alabama, United States
- Banner Thunderbird Medical Center, Glendale, Arizona, United States
- Banner-University Medical Center Phoenix, Phoenix, Arizona, United States
- Western Regional CCOP, Phoenix, Arizona, United States
- Scottsdale Healthcare, Scottsdale, Arizona, United States
- University of Arkansas for Medical Sciences, Little Rock, Arkansas, United States
- Long Beach Memorial Medical Center-Todd Cancer Institute, Long Beach, California, United States
- UCLA / Jonsson Comprehensive Cancer Center, Los Angeles, California, United States
- Community Hospital of Los Gatos, Los Gatos, California, United States
- Palo Alto Medical Foundation-Gynecologic Oncology, Mountain View, California, United States
- UC Irvine Health/Chao Family Comprehensive Cancer Center, Orange, California, United States
- UCSF Medical Center-Mount Zion, San Francisco, California, United States
- North Colorado Medical Center, Greeley, Colorado, United States
- McKee Medical Center, Loveland, Colorado, United States
- Hartford Hospital, Hartford, Connecticut, United States
- +15 more locations on ClinicalTrials.gov
Collaborators
National Cancer Institute (NCI)
Primary source
Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.
Open NCT00006227 on ClinicalTrials.gov